Slide 1: FY25 Results Investor Presentation
ASX:VFX FY25 Results Investor Presentation 29 AUGUST 2025 This announcement was approved for release by the Board of Directors. FY25 RESULTS INVESTOR PRESENTATION / AUGUST 2025 / 1
Slide 2: The Visionflex mission
The Visionflex mission Empowering health practitioners globally with cutting edge technologies to elevate patient outcomes. Visionflex proprietary software and hardware connect a range of third-party medical devices to empower practitioners to deliver world class virtual care. F Y 2 5 R E S U L T S
Slide 3: Hardware
Hardware Visionflex hardware enables health practitioners to virtually conduct medical examinations with confidence and serves as a foundational step for establishing long term software subscriptions. PERIPHERALS + SOFTWARE DEVICE + PERIPHERALS + SOFTWARE MEDICAL CART + PERIPHERALS + SOFTWARE Mobile
Slide 4: Proprietary Software (Virtual Care Platform)
Proprietary Software (Virtual Care Platform) A clinically capable comprehensive virtual healthcare platform empowering practitioners to virtually examine, diagnose, monitor and treat patients remotely. Perform collaborative, clinical, evidence-based A user-friendly video conferencing platform that d
Slide 5: Revenue Model
Revenue Model Offering Core HARDWARE SOFTWARE Key Product / Services Revenue Streams UPFRONT / ONE-OFF RECURRING REVENUE $5k – $30k per unit depending on solution ~$5k per annum for annual software license margin 60-65% GP margin 90-95% GP margin GP Revenue Repeat Each new software license typically
Slide 6: Key customers by market segment
Key customers by market segment PRIMARY HEALTH NETWORKS AGED CARE CORPORATES LOCAL HEALTH DISTRICTS INDIGENOUS HEALTH & OTHER HEALTH BODIES INTERNATIONAL FY25 RESULTS INVESTOR PRESENTATION / AUGUST 2025 / 6
Slide 7: FY25 Highlights
FY25 Highlights FY25 RESULTS INVESTOR PRESENTATION / AUGUST 2025 / 77
Slide 8: FY25 Financial Summary
FY25 Financial Summary Business model transition leading to material ARR growth which will underpin future profitability. Visionflex revenue Subscription revenue Gross margin Underlying EBITDA 2 Annual Recurring Revenue (Software and support) $4.7m $1.4m 78% ($2.5m) $1.9m 33% 1 101% 17% ($1.8m) 49%
Slide 9: Key Customer Wins – FY25
Key Customer Wins – FY25 Visionflex is now trusted by leading organisations across the health sector. Deploy Visionflex solution in a National reseller agreement Deploy Visionflex solution Expansion into the private transformative Aust gov’t signed to deliver virtual care across 13 medical centres a
Slide 10: Key Customer Wins – FY25
Key Customer Wins – FY25 Driving revenue expansion within established customer relationships. Upgrade 180 sites with new Expanded to 20 additional Selected via a competitive Expanded to 7 additional battery units enhancing facilities and added tender process with initial facilities and added solutio
Slide 11: FY25 Financial Overview
FY25 Financial Overview FY25 RESULTS INVESTOR PRESENTATION / AUGUST 2025 / 1 11 1
Slide 12: Financial Dashboard
Financial Dashboard Strategic transition to SaaS delivers strong recurring high margin growth. Revenue Revenue (by type) (by region) ~49% ARR Underlying Growth ~326% EBITDA FY25 RESULTS INVESTOR PRESENTATION / AUGUST 2025 / 12
Slide 13: Profit & Loss
Profit & Loss Strong growth in recurring software licenses underpin rationale for transitioning business model. With a a number of larger enterprise opportunities, expectation of a significantly strong financial result in FY26. 1• Robust growth in recurring subscription revenue highlights the Compan
Slide 14: Cash Flow Statement
Cash Flow Statement Operating cash flow is expected to rebound in FY26, with long-term stability supported by recurring software revenue. 1• Reduction in customer receipts reflects corresponding revenue movements and delayed 1 enterprise sales. 2 2• Focus on delivering efficiencies in the cost base
Slide 15: Balance Sheet
Balance Sheet Improved balance sheet strength provides the financial capacity to capitalise on growth opportunities. 1 1• $1.9m cash in the bank provides a strong base to deliver growth objectives in FY26. 2• The current ratio improved from 70% to 88%, reflecting a stronger liquidity position and an
Slide 16: FY26 Outlook
FY26 Outlook FY25 RESULTS INVESTOR PRESENTATION / AUGUST 2025 / 1 16 6
Slide 17: Outlook – FY26 & Beyond
Outlook – FY26 & Beyond Strategic plan to deliver Transitioning to recurring Expanding pipeline Product Innovation profitable growth revenue via SaaS of customers Positive momentum - operating Transition to SaaS pricing Multiple government funded New market-ready solution – cashflow positive $0.3m i
Slide 18: Important notices
Important notices This results presentation (Presentation) has been prepared by Visionflex Group Limited ACN 138 897 533 (ASX:VFX) (Company) and is dated 29 August 2025. A number of figures, amounts, percentages, estimates, calculations of values and fractions in this Presentation are subject to the
Slide 19: Joshua Mundey
Visionflex Group Limited Unit 1, 8 Prosperity Parade Warriewood NSW 2102 Joshua Mundey MANAGING DIRECTOR & CEO E: jmundey@visionflex.com VFX-GROUP.COM FY25 RESULTS INVESTOR PRESENTATION / AUGUST 2025 / 1 19 9